ATI Pharm Final Test Bank 2021 Questions and Answers Latest Update 2022 & 100- Verified.pdf

ATI NR293 PHARM FINAL REVIEW CORRECT QUESTIONS
k k k k k k




AND ANSWERS/2023.Qualified,VSU
k




1) Aknursekiskassessingkakclientkwhokisktakingklevothyroxine.kTheknursekshouldkrecognizekthatkwhichkofkthekfollowingkfin
dingskiskakmanifestationkofklevothyroxinekoverdose?
a) Insomnia
i) Rationale: Levothyroxine overdose will result in manifestations of hyperthyroidism,which include Inso
k k k k k k k k k k k



mnia,ktachycardia,kandkhyperthermia.
b) Constipation
i) Rationale: Constipation is a manifestation of hypothyroidism and indicates aninadequate dose
k k k k k k k k k k k k



ofklevothyroxine.
c) Drowsiness
i) Rationale: Drowsiness is a manifestation of hypothyroidism and indicates aninadequate dose
k k k k k k k k k k k k



ofklevothyroxine.
d) Hypoactivekdeep-tendonkreflexes
i) Rationale: Hypoactive deep-
k k



tendonkreflexeskarekmanifestationskofkhypothyroidismkandkindicatekankinadequatekdosekofklevothyroxi
ne.


2) Aknursekiskreviewingkthekmedicalkrecordkofkakclientkwhokhaskbeenkonklevothyroxinekforkseveralkmonths.kWhichkofkt
hekfollowingkfindingskindicateskaktherapeutickresponsektokthekmedication?
a) Decreasekinklevelkofkthyroxinek(T4)

i) Rationale: If the dose of this medication has been adequate, the nurse should see an increasein the T4.
k k k k k k k k k k k k k k k k k k



b) Increasekinkweight
i) Rationale: If the dose of this medication has been adequate, the nurse should see a decrease in weight, as hyp
k k k k k k k k k k k k k k k k k k k



othyroidismkcauseskakdecreasekinkmetabolismkwithkweightkgain.
c) Increasekinkhrkofksleepkperknight
i) Rationale: If the dose of this medication has been adequate, the nurse should see adecrease in the hr of
k k k k k k k k k k k k k k k k k k k



sleepkperknight,kaskhypothyroidismkcausesksluggishnesskwithkincreasedkhrkofksleep.
k



d) Decreasekinklevelkofkthyroidkstimulatingkhormonek(TSH).
i) Rationale: In hypothyroidism, the nonfunctioning thyroid gland is unable to respond to the TSH, and no endoge
k k k k k k k k k k k k k k k k

,ATI NR293 PHARM FINAL REVIEW CORRECT QUESTIONS
k k k k k k




AND ANSWERS/2023.Qualified,VSU
k




nouskthyroidkhormoneskarekreleased.kThiskresultskinkank elevationkofkthekTSHklevelkaskthekanteriorkpituitarykcontin
uesktokreleasekthekTSHktokstimulatekthekthyroidkgland.kAdministrationkofkexogenouskthyroidhormones,ksuchkasklev
othyroxine,kturnsko ff k thiskfeedbackkloop,kwhichkresultskinkakdecreasedklevelkofkTSH.


3) Aknursekiskreviewingkthekmedicationklistkforkakclientkwhokhaskaknewkdiagnosiskofktypek2kdiabeteskmellitus.kTheknurses
houldkrecognizekwhichkofkthekfollowingkmedicationskcankcausekglucosekintolerance?
a) Ranitidine
i) Serum creatinine levels
k k



b) Guafenesin
i) Drowsiness and dizziness
k k

,ATI NR293 PHARM FINAL REVIEW CORRECT QUESTIONS
k k k k k k




AND ANSWERS/2023.Qualified,VSU
k




c) Prednisone
i) Glucose intolerance and hyperglycemia, patient might require increased dosage ofhypoglycemic med.
k k k k k k k k k k k



d) Atorvastatin
i) Thyroid function tests.
k k




4) Aknursekiskcaringkforkakclientkreceivingkmydriatickeyekdrops.kWhichkofkthekfollowingkclinicalkmanifestationskindic
atesktotheknursekthatkthekclientkhaskdevelopedkaksystemickanticholinergickeffect?
a) Seizures
b) Tachypnea
c) Constipation
i) Mydriatic eye drops can cause systemic anticholinergic effects such asconstipation, dry
k k k k k k k k k k k



mouth,photophobia,kandktachycardia.
k



d) Hypothermia

, ATI NR293 PHARM FINAL REVIEW CORRECT QUESTIONS
k k k k k k




AND ANSWERS/2023.Qualified,VSU
k




5) AknursekiskcaringkforkakclientkwhokhaskheartkfailurekandkiskreceivingkIVkfurosemide.kTheknursekshouldkmonitorkthekcl
ientkforkwhichkofkthekfollowingkelectrolytekimbalances?


a) Hypernatremia


i) Rationale: The nurse should monitor the client who is receiving IV furosemide forhyponatremia.
k k k k k k k k k k k k k




b) Hyperuricemia



i)kRationale:kTheknursekshouldkmonitorkthekclientkwhokiskreceivingkIVkfurosemidekforkhyperuricemia.kTheknursekshould
nstructkthekclientktoknotifykthekproviderkforkanyktendernesskorkswellingkofkthekjoints.


c) Hypercalcemia


i) Rationale:kTheknursekshouldkmonitorkthekclientkwhokiskreceivingkIVkfurosemidekforkhypocalcemia.


d) Hyperchloremia


i) Rationale:kTheknursekshouldkmonitorkthekclientkwhokiskreceivingkIVkfurosemidekforkhypochloremia.




6) Aknursekisktalkingktokakclientkwhokisktakingkakcalciumksupplementkforkosteoporosis.kThekclientktellsktheknursekshekis
experiencingkflankkpain.kWhichkofkthekfollowingkadversekeffectskshouldktheknurseksuspect?


a) Renalkstones